Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.


Strengths

● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.49 for the 2022 fiscal year.

● The company has a low valuation given the cash flows generated by its activity.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For several months, analysts have been revising their EPS estimates roughly upwards.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Analyst opinion has improved significantly over the past four months.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● The company's earnings growth outlook lacks momentum and is a weakness.

● As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.

● The company has insufficient levels of profitability.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.